NCT06708299Phase 3Recruiting

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

Study sponsor: Cardiol Therapeutics Inc. · CRDL

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-21Estimated
Enrollment · participants110Estimated
Source updated2026-09-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Recurrence of pericarditis. After: Measure: time to pericarditis recurrence.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview